Federal Supply Schedule 36F79724D0026
Award Date
11/15/23
Last Date to Order
11/14/28
Federal Agency
Veterans Integrated Service Network 12
Awardee
Immunocore Commercial LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Federal Supply Schedule (FSS) contract 36F79723D035E awarded to Immunocore Commercial LLC by the U.S. Department of Veterans Affairs (VA) is an interim agreement focused on delivering drugs, pharmaceuticals, and hematology-related products under Federal Supply Classification 65 I B. The $25,000 ceiling value contract has an ultimate completion date of November 14, 2023. Immunocore Commercial LLC, a foreign-owned for-profit manufacturer of goods, has been consistently awarded delivery...
The National Acquisition Center, a civilian agency of the U.S. Department of Veterans Affairs (VA), has awarded a Blanket Purchase Agreement (BPA) contract to Immunocore Commercial LLC, a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $4,000,000.00 single-award IDV, contract number 36F79724D0026, has an ultimate completion date of April 9, 2026 and covers the procurement of KIMMTRAK (tebentafusp-tebn), a 100MCG/0.5ML injectable pharmaceutical product. Immunocore Commercial...
This federal contract IDV is an interim agreement awarded under Federal Supply Schedule (FSS) 65 IB, which covers drugs, pharmaceuticals, and hematology-related products. The contract was awarded by the Veterans Integrated Service Network 12, a civilian agency of the U.S. federal government, to Immunogen Inc., a for-profit organization, on December 16, 2022. The contract has a ceiling value of $25,000.00 and an ultimate completion date of June 14, 2023. The purpose of this contract is to provide...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded to Adaptimmune LLC, a foreign-owned, for-profit manufacturer of goods. The contract, valued at up to $25,000.00, is for the procurement of drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a period of performance from...
The Federal Supply Schedule contract with ID 36F79723D0147 was awarded by the Department of Veterans Affairs to the prime contractor Immunogen Inc., a subsidiary of Abbvie Inc. The contract is classified under the FSS category "65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" and has a total ceiling value of $225,000.00 with a period of performance through June 14, 2028. As a Federal Supply Schedule contract, this vehicle provides federal agencies with a streamlined...
The federal contract IDV award is for a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for "65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS." The prime contractor is Kamada Inc., a foreign-owned for-profit organization. The contract has a ceiling value of $750,000.00 and a period of performance from July 1, 2024 to June 30, 2029. The contract was awarded without any set-asides and is a multiple award. As an FSS contract, it...
The federal contract IDV award is a multiple-award Federal Supply Schedule (FSS) contract under Schedule 61-IB for Pharmaceuticals and Drugs, awarded by the U.S. Department of Veterans Affairs (VA) to Therakos, Inc., a foreign-owned, for-profit corporation. The contract has a ceiling value of $750,000 and a period of performance through January 2026. Under this IDV, the VA and other federal agencies such as the National Institutes of Health (NIH) Clinical Center have issued delivery orders to...
This federal contract IDV is a Federal Supply Schedule (FSS) awarded by the Department of Veterans Affairs (VA) to Kamada Inc., a foreign-owned for-profit organization. The contract is for DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS under FSS Schedule 65 I B, with a ceiling value of $25,000.00 and a period of performance from January 16, 2024 to July 14, 2024. The contract is a multiple award vehicle, meaning it allows for the placement of task orders against the schedule by...
The federal contract IDV is a Federal Supply Schedule awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The $340,000,000 contract was awarded to EMD Serono Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods, for a period of performance from January 1, 2025 to December 31, 2029. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Immunomedics, Inc. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Master GSA Schedule, with a potential value of $10,000,000. The period of performance is January 1, 2021 through December 31, 2025. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for the VA network through task...